U.S. markets closed

  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     

  • Dow 30

    33,761.05
    +424.38 (+1.27%)
     

  • Nasdaq

    13,047.19
    +267.27 (+2.09%)
     

  • Russell 2000

    2,016.62
    +41.36 (+2.09%)
     

  • Crude Oil

    91.88
    -2.46 (-2.61%)
     

  • Gold

    1,818.90
    +11.70 (+0.65%)
     

  • Silver

    20.83
    +0.49 (+2.39%)
     

  • EUR/USD

    1.0257
    -0.0068 (-0.66%)
     

  • 10-Yr Bond

    2.8490
    -0.0390 (-1.35%)
     

  • GBP/USD

    1.2139
    -0.0064 (-0.52%)
     

  • USD/JPY

    133.4800
    +0.4810 (+0.36%)
     

  • BTC-USD

    24,129.66
    -65.84 (-0.27%)
     

  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     

  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     

  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

Voyager Therapeutics' Vectorized Anti-Tau Antibody Shows Encouraging Preclinical Data In CNS Disorders

  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • VYGR

  • Voyager Therapeutics Inc (NASDAQ: VYGR) has announced new preclinical data characterizing the durable expression and activity of a vectorized anti-tau antibody.

  • The results will be presented at the American Society of Gene and Cell Therapy.

  • Data demonstrate durable expression in the central nervous system (CNS). They may represent a new single-dose therapeutic strategy for treating various tauopathies such as progressive supranuclear palsy, frontal, temporal dementia, and Alzheimer's disease.

  • Voyager has developed modular antibody vectorization cassettes consisting of an adeno-associated virus (AAV) vector and a transgene encoding anti-tau monoclonal full-length antibodies.

  • Following intravenous administration and transduction of target cells in the brain, the expressed antibodies are functionally reconstituted and subsequentially secreted into the parenchyma.

  • Anti-tau antibody expression was detected as early as two days post-dose, reaching maximum levels at day 7, with durable expression extending to 28 days.

  • Dose-dependent decreases in the levels of pathological tau and neurofibrillary tangles were observed, resulting in up to 59% reduction in tau pathology.

  • Price Action: VYGR shares are trading 2.5% higher at $4.51 on the last check Wednesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • SNDL Reports Second Quarter 2022 Financial and Operational Results

    SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the second quarter ended June 30, 2022. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. All results for the second quarter of 2021 exclude the subsequent acquisitions of Inner Spirit Holdings ("Spiritleaf") and Alcanna Inc. ("Alcanna"), which closed on July 20, 2021, and March 31, 2022, respectively.

  • Outgoing Whole Foods CEO says young people ‘don’t seem like they want to work’ and thinks ‘socialists are taking over’

    John Mackey is bowing out in the battle between CEOs and a new generation entering the workforce, but as he told "Reason," he’s not leaving silently.

  • 10 EV Stocks that Will Benefit from Climate Change Bill 2022

    In this article, we will discuss 10 EV stocks that will benefit from the Climate Change Bill 2022. If you want to skip reading about the details of the bill, go directly to 5 EV Stocks that Will Benefit from Climate Change Bill 2022. On August 7, the U.S. Senate approved a comprehensive $430 billion […]

  • Billionaire Mark Cuban Takes Surprise Stance on Controversial New Tax

    The entrepreneur Mark Cuban just took a stand in a debate that's hotly controversial in business circles and Congress.

  • 11 Best Falling Stocks To Buy Now

    In this article, we talk about 11 best falling stocks to buy now. If you wish to skip our detailed analysis of the latest market situation, go directly to 5 Best Falling Stocks To Buy Now. After a brutal 2022 which saw the S&P500 shed more than 21% in the first half of the year, Q2 […]

  • Devon Energy's (NYSE:DVN) Upcoming Dividend Will Be Larger Than Last Year's

    The board of Devon Energy Corporation ( NYSE:DVN ) has announced that it will be paying its dividend of $1.55 on the...

  • Wide-body jet demand humming again as Boeing 787 rejoins the fray

    Boeing Co's 787 Dreamliner has returned to the world market for newly delivered aircraft at a time when demand for wide-body jetliners is finally stirring to life after a prolonged slump. The U.S. planemaker delivered its first Dreamliner since May 2021 on Wednesday, in a significant milestone for the manufacturer after production problems with its wide-body jet. Boeing must now wade through painstaking regulatory checks to get further 787s delivered while chipping away at a backlog of about 120 stored planes outside its plants.

  • Tesla bull issues a $1,150 price target for the stock

    Yahoo Finance Live's Brian Sozzi breaks down the stat of the day.

  • Ryan Reynolds spent nearly $3 million before consulting his wife Blake Lively: ‘We’re still working through that one’

    Financial planners share how much spouses should be able to comfortably spend from joint income.

  • UNITY Biotech Shares More Than Double On Positive Drug Data For Diabetes Associated Vision Loss

    UNITY Biotechnology Inc (NASDAQ: UBX) shares are skyrocketing after 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325 for diabetic macular edema (DME). DME is a diabetic complication that affects the blood vessels in the back of your eye. At 18 weeks after a single UBX1325 injection, the mean change in BCVA of UBX1325-treated subjects was an increase of 6.1 ETDRS letters, representing an improvement of +5.0 ETDRS letters compared to sham-treated subjects. Related: UNITY Biotech Stock

  • Investors are Shorting These 10 Chinese Stocks

    In this article, we discuss 10 Chinese stocks investors are shorting. If you want to skip our discussion about the turmoil in the Chinese economy, go directly to Investors are Shorting These 5 Chinese Stocks. NIO Inc. (NYSE:NIO), KE Holdings Inc. (NYSE:BEKE), and TAL Education Group (NYSE:TAL) are some of the stocks that investors are […]

  • Stocks to watch in after hours: Peloton, Apple, DraftKings, Bed Bath & Beyond

    These are the top trending tickers on Yahoo Finance after-hours on Aug. 12.

  • Blow for Germany as Rhine falls below critical water level

    Western sanctions have ‘limited impact’ on Putin regime, warns International Energy Agency GDP fell by 0.1pc in second quarter, first decline since early 2021 FTSE 100 adds 0.5pc Ambrose Evans-Pritchard: The next PM should not be bounced into stupid energy policies by this mood of near hysteria Sign up here for our daily business briefing newsletter

  • Rivian: Q2 earnings takeaways

    Yahoo Finance's Pras Subramanian breaks down Rivian earnings, production, Q2 loss, and the outlook for the stock.

  • Powell Needs to Speak Up to Stop Ill-Fated Market Rally, Strategist Says

    (Bloomberg) -- Principal Global Investors’ Seema Shah is no stock market bull but says the rally that erupted Wednesday may continue until the head of the Federal Reserve steps up and stops it.Most Read from BloombergStriking Drop in Stress Hormone Predicts Long Covid in StudyThe Fed’s Damage to the Housing Market May Last YearsGarland Seeks to Unseal Trump Warrant, Says He Approved SearchChina Has Painted Itself Into a Semiconductor CornerRuto, Odinga Shy of Victory in Latest Vote Counts: Kenya

  • How Charged Up Is FuelCell?

    With the imminent passing of the inflation reduction act, which is going to pour money into green energy projects, we are seeing a lot of green names blow higher. ChargePoint , Blink , Plug Power , even lowly FuelCell Energy is up 6.

  • Kevin O'Leary says these are the best assets to own as inflation stays white hot

    Inflation is still near multi-decade highs. Mr. Wonderful is using these stocks to fight back.

  • Three Chinese corporate giants are leaving the New York Stock Exchange

    Three state-owned Chinese corporate giants announced plans Friday to remove their shares from the New York Stock Exchange, adding to a growing financial separation between the biggest global economies in the midst of a dispute over scrutiny of company audits.

  • Inflation report brings 2 pieces of good news for retirees and retirement savers

    Retirees and those seeking secure income got two items of very good news this week, though you may only have heard about one. July’s inflation came in below fears (although a debate now rages on what the “real” inflation rate is—more on that below). Meanwhile, your ability to earn a guaranteed rate of return on risk-free investments, regardless of what happens to inflation, actually went up.

  • 10 Best Blue Chip Dividend Stocks to Buy in August

    In this article, we discuss 10 best blue chip dividend stocks to buy in August. You can skip our detailed analysis of dividend stocks and their importance in the current market environment, and go directly to read 5 Best Blue Chip Dividend Stocks to Buy in August. The current market environment has forced investors to […]